(Q45878150)

17 December 2017

title

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells (English)

1 reference

17 December 2017

1 reference

Hombach A

1

1 reference

17 December 2017

Muche JM

2

1 reference

17 December 2017

Gerken M

3

1 reference

17 December 2017

Gellrich S

4

1 reference

17 December 2017

Heuser C

5

1 reference

17 December 2017

Pohl C

6

1 reference

17 December 2017

Sterry W

7

1 reference

17 December 2017

Abken H

8

1 reference

17 December 2017

publication date

1 June 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

891-895

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301467

exact match

0 references

cites work

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301467

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301467

1 reference

17 December 2017

Dimensions Publication ID

1044105726

0 references

1 reference

17 December 2017